[1]
L. Petrenko and E. Rekalova, “Efficiency of antifungal sublingual allergen-specific immunotherapy in patients under and over 50 years old with mild persistent and moderate bronchial asthma”, ScienceRise: Medical Science, no. 4 (12), pp. 36–41, Apr. 2017.